openPR Logo
Press release

Rotavirus Vaccine Market Size, Analysis, Competitive Strategies and Forecasts, 2017-2021 - QY Research Reports

04-18-2017 10:54 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: qyresearchreports.us

qyresearchreports.us

qyresearchreports.us

To Ask For a Sample Copy Of This Report, Please Visit: https://www.qyresearchreports.us/request-sample/global-rotavirus-vaccine-market-research-report-2017
How Effective is Rotavirus Vaccine?

Rotavirus is a virus which leads to severe diarrhea along with vomiting. This virus is known to affect mostly young children and babies. In fact the diarrhea can be so serious that it can result in extreme dehydration along with high fever. Way before rotavirus vaccine was ever developed; this disease was considered to be very common and grave for children in the United States. In fact statistics after the study on rotavirus vaccine market shows that almost every child in the United States did have rotavirus infection before they turned five years of age. Rotavirus gets channeled and transferred by the fecal-oral route, and the infection damages the cells which line the small intestine and eventually leads to gastroenteritis, commonly known as stomach flu. In 1973, Ruth Bishop along with her colleagues discovered rotavirus with the help of electron micrograph images and is responsible for nearly one third of hospital care for severe diarrhea in children. However, its significance has in the past been undervalued in the public health community, especially in developing countries.

Symptoms pertaining to rotavirus:

• Watery diarrhea
• Fever
• Stomach pain
• Vomiting

Vomiting and diarrhea in severe cases might last up to three to eight days, during which children might refuse to eat or drink anything.

Vaccination for Rotavirus:

Rotavirus vaccines help in preventing almost 37 to 96 percent severe diarrhea in the developed world, and 15 to 34 percent of severe diarrhea in the developing world. These vaccines seem to reduce the death risk among children because of diarrhea. The rotavirus vaccines - precludes children from acquiring vomiting, diarrhea and stomach pain from rotavirus, and safeguards children from rotavirus.

In the United States, there are two rotavirus vaccines that are licensed for vaccinating children – Rotarix and RotaTeq. Both these vaccines are administered orally and not injected. It has been suggested that rotavirus vaccines are very efficient when the first dose is given before a child is of 15 weeks, and rest of the dosages must be complete by 8 months.

• Rotarix (RV1) is administered on a plan of two doses, at ages two months and four months.
• RotaTeq (RV5) is administered on a plan of three doses at 2, 4 and 6 months of age respectively.

Lastly, rotavirus vaccines will not arrest vomiting and diarrhea which has been caused by other germs. Also, a virus called porcine circovirus can be determined in both the above mentioned vaccines. However, this virus does not infect people and there is no such established safety risk associated.

In order to Browse the Complete Report, Please Visit: https://www.qyresearchreports.us/market-analysis/global-rotavirus-vaccine-market-research-report-2017
Table of Contents

Global Rotavirus Vaccine Market Research Report 2017
1 Rotavirus Vaccine Market Overview
1.1 Product Overview and Scope of Rotavirus Vaccine
1.2 Rotavirus Vaccine Segment by Type
1.2.1 Global Production Market Share of Rotavirus Vaccine by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.3 Rotavirus Vaccine Segment by Application
1.3.1 Rotavirus Vaccine Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.4 Rotavirus Vaccine Market by Region
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 China Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Rotavirus Vaccine (2012-2022)

2 Global Rotavirus Vaccine Market Competition by Manufacturers
2.1 Global Rotavirus Vaccine Production and Share by Manufacturers (2015 and 2016)
2.2 Global Rotavirus Vaccine Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Rotavirus Vaccine Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Rotavirus Vaccine Manufacturing Base Distribution, Sales Area and Product Type
2.5 Rotavirus Vaccine Market Competitive Situation and Trends
2.5.1 Rotavirus Vaccine Market Concentration Rate
2.5.2 Rotavirus Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
….
Enquiry Before Buying @ https://www.qyresearchreports.us/send-an-enquiry/global-rotavirus-vaccine-market-research-report-2017

QY Research is your exclusive destination for the entire spectrum of Market Research and Business Solutions. Depending upon the clients, we provide customized as well as syndicated reports. Our market intelligence covers industries like technology, food and beverages, chemical materials, pharmaceuticals and healthcare, agriculture, consumer goods, among others.

Contact Us:
11323 136th Ave East
Puyallup, Wa 98374
United States
Email – Sales@Qyresearchreports.Us

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rotavirus Vaccine Market Size, Analysis, Competitive Strategies and Forecasts, 2017-2021 - QY Research Reports here

News-ID: 503475 • Views: 126

More Releases from qyresearchreports.us

SUV Ignition Coil Market Supply & Demand Research Report 2017
QY Research Reports analysts estimate the SUV Ignition Coil Market to grow at a substantial CAGR during the forecast period 2017 to 2022. In this report, the global SUV Ignition Coil market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions,
Fistula Needles Market to See Strong Application Scope Globally from 2017 to 202 …
QY Research Reports analysts estimate the Fistula Needles Market to grow at a substantial CAGR during the forecast period 2017 to 2022. This report studies Fistula Needles in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. Get Sample Copy of this Report: https://www.qyresearchreports.us/request-sample/global-fistula-needles-market-professional-survey-report-2017-d-1963 This report focuses on top manufacturers
Pen Needles Market Report for Period 2017 till 2022
QY Research Reports analysts estimate the Pen Needles Market to grow at a substantial CAGR during the forecast period 2017 to 2022. This report studies Pen Needles in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. Get Sample Copy of this Report: https://www.qyresearchreports.us/request-sample/global-pen-needles-market-professional-survey-report-2017-d-1961 This report focuses on top manufacturers
Biopsy Needles Market Demand Growth Analysis 2017 To 2022
QY Research Reports analysts estimate the Biopsy Needles Market to grow at a substantial CAGR during the forecast period 2017 to 2022. This report studies Biopsy Needles in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. Get Sample Copy of this Report: https://www.qyresearchreports.us/request-sample/global-biopsy-needles-market-professional-survey-report-2017-d-1959 This report focuses on top manufacturers

All 5 Releases


More Releases for Rotavirus

Global Oral Rotavirus Vaccine Market 2020 Industry Status
This report also researches and evaluates the impact of Covid-19 outbreak on the Oral Rotavirus Vaccine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Oral Rotavirus Vaccine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.). GLOBAL INFO RESEARCH indicates that the global Oral Rotavirus Vaccine market is expected to surge at a steady rate in the coming years, as economies flourish. The
Rotavirus Infections Global Market Research Report 2025
Rotavirus Infections Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/rotavirus-infections-market/81019 The report firstly introduced the Rotavirus Infections basics: definitions, classifications, applications and market
Rotavirus Infections Therapeutics Market Future Opportunities 2017-2025
Rotavirus infections cause vomiting and diarrhea that leads to severe dehydration. Despite widespread cell death and tissue damage, the inflammatory reaction is quite limited. Rotavirus is the major cause of acute gastroenteritis in young children globally, and accounts for 600,000 child deaths each year, with the majority of deaths occurring in Middle East & Africa and Asia Pacific. The primary clinical symptoms of rotavirus infections are severe vomiting and diarrhea,
Rotavirus Infections Therapeutics Market Pegged for Robust Expansion by 2025
Rotavirus infections cause vomiting and diarrhea that leads to severe dehydration. Despite widespread cell death and tissue damage, the inflammatory reaction is quite limited. Rotavirus is the major cause of acute gastroenteritis in young children globally, and accounts for 600,000 child deaths each year, with the majority of deaths occurring in Middle East & Africa and Asia Pacific. The primary clinical symptoms of rotavirus infections are severe vomiting and diarrhea,
01-12-2018 | Health & Medicine
TMR
Rotavirus Diagnostics Market – Stratergies, Growth, Latest Trend & Forecast 20 …
Rotavirus is a major cause of severe childhood gastroenteritis. Rotavirus, the most significant member of the Reoviridae family, is responsible for almost two million hospital admissions, around 25 million clinic visits, and more than 0.8 million deaths among children below the age of five globally each year. Rotavirus has a worldwide incidence, both in developed and developing countries; however, maximum deaths have been observed in the developing countries. It is
Rotavirus Diagnostics Market: Future market projections for forthcoming years
Rotavirus is a major cause of severe childhood gastroenteritis. Rotavirus, the most significant member of the Reoviridae family, is responsible for almost two million hospital admissions, around 25 million clinic visits, and more than 0.8 million deaths among children below the age of five globally each year. Rotavirus has a worldwide incidence, both in developed and developing countries; however, maximum deaths have been observed in the developing countries. It is